Bionano Genomics (BNGO) News Today $0.20 -0.01 (-2.74%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Bionano Genomics urges stockholders to support proposals at special meetingDecember 19 at 3:00 PM | markets.businessinsider.comBionano Genomics (NASDAQ:BNGO) Stock Price Down 6% - Here's What HappenedDecember 18 at 1:53 AM | americanbankingnews.comBionano Genomics announces presentations at ASH annual meetingDecember 11, 2024 | markets.businessinsider.comHold Rating on BioNano Genomics Amid Revenue Shortfall and Strategic ShiftNovember 19, 2024 | markets.businessinsider.comLadenburg downgrades Bionano Genomics on restructuring uncertaintyNovember 16, 2024 | markets.businessinsider.comScotiabank Sticks to Their Hold Rating for BioNano Genomics (BNGO)November 16, 2024 | markets.businessinsider.comBionano Genomics, Inc. (NASDAQ:BNGO) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comLadenburg Thalmann Downgrades Bionano Genomics (BNGO)November 16, 2024 | msn.comBionano Genomics Sees Growth in OGM AdoptionNovember 14, 2024 | markets.businessinsider.comBionano Genomics reports Q3 revenue $6.1M, consensus $7.85M.November 14, 2024 | markets.businessinsider.comBionano Genomics (BNGO) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | finance.yahoo.comBionano Genomics, Inc. (BNGO) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comBionano Reports Third Quarter 2024 Results and Highlights Recent Business ProgressNovember 13, 2024 | globenewswire.comOptical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the IndustryNovember 4, 2024 | globenewswire.comBionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesOctober 31, 2024 | globenewswire.comBionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesOctober 31, 2024 | markets.businessinsider.comBionano Adjourns Special Meeting of Stockholders to November 27, 2024October 31, 2024 | globenewswire.comBionano Genomics announces publication outlining utility of OGMOctober 26, 2024 | markets.businessinsider.comBionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple MyelomaOctober 24, 2024 | markets.businessinsider.comBionano Genomics: Bionano Announces Preliminary 3Q 2024 Revenues and CashOctober 12, 2024 | finanznachrichten.deBionano Genomics cuts Q3 revenue view to $6.5M-$6.8M from $7.9M-$8.9MOctober 10, 2024 | msn.comBionano Announces Preliminary 3Q 2024 Revenues and CashOctober 10, 2024 | globenewswire.comBionano Genomics Inc (BNGO) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ...October 10, 2024 | finance.yahoo.comBTIG downgrades BioNano Genomics (BNGO) to a HoldSeptember 11, 2024 | markets.businessinsider.comBTIG downgrades Bionano to Neutral after fourth workforce reductionSeptember 11, 2024 | msn.comBTIG Downgrades Bionano Genomics (BNGO)September 11, 2024 | msn.comBionano to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment ConferenceSeptember 4, 2024 | finance.yahoo.comScotiabank Downgrades Bionano Genomics (BNGO)August 29, 2024 | msn.comRVTY Dec 2024 145.000 call (RVTY241220C00145000)August 26, 2024 | finance.yahoo.comBNGO Sep 2024 1.500 call (BNGO240920C00001500)August 26, 2024 | sg.finance.yahoo.comRVTY Mar 2025 115.000 put (RVTY250321P00115000)August 18, 2024 | finance.yahoo.comBNGO Sep 2024 2.000 put (BNGO240920P00002000)August 18, 2024 | finance.yahoo.comBuy Rating Affirmed for BioNano Genomics Amidst Operational Progress and Strategic Financial PlanningAugust 15, 2024 | markets.businessinsider.comMaxim Group Reaffirms Their Hold Rating on BioNano Genomics (BNGO)August 11, 2024 | markets.businessinsider.comBionano Genomics, Inc. (NASDAQ:BNGO) Q2 2024 Earnings Call TranscriptAugust 8, 2024 | msn.comBionano Genomics (BNGO) Q2 2024 Earnings Call TranscriptAugust 8, 2024 | msn.comBionano Reports Second Quarter 2024 Results and Highlights Recent Business ProgressAugust 7, 2024 | globenewswire.comBionano to Present at the Canaccord Genuity 44th Annual Growth ConferenceJuly 31, 2024 | globenewswire.comBionano Genomics Inc.July 24, 2024 | barrons.comBionano Announces Publication of First Multi-Site Study to Analyze the Utility of OGM in Multiple MyelomaJuly 24, 2024 | markets.businessinsider.comBNGO Jan 2025 5.000 putJuly 23, 2024 | ca.finance.yahoo.comBionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJuly 8, 2024 | globenewswire.comBionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJuly 5, 2024 | globenewswire.comScientific Presentations Highlight OGM's Utility for Cancer Research at Joint Annual Meeting for Three Molecular and Cytogenetic AssociationsJuly 2, 2024 | globenewswire.comBionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing ResearchJune 20, 2024 | globenewswire.comBionano Genomics, Inc. (NASDAQ:BNGO) Short Interest Down 5.8% in MayBionano Genomics, Inc. (NASDAQ:BNGO - Get Free Report) saw a significant decrease in short interest in the month of May. As of May 31st, there was short interest totalling 4,690,000 shares, a decrease of 5.8% from the May 15th total of 4,980,000 shares. Currently, 6.9% of the company's stock are short sold. Based on an average daily trading volume, of 1,300,000 shares, the short-interest ratio is currently 3.6 days.June 18, 2024 | marketbeat.comBionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy AnalysisJune 17, 2024 | globenewswire.comBionano Genomics (NASDAQ:BNGO) Stock Price Down 2.9%Bionano Genomics (NASDAQ:BNGO) Shares Down 2.9%June 7, 2024 | marketbeat.com3 Sorry Healthcare Stocks to Sell in May While You Still CanMay 28, 2024 | investorplace.comBionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance SheetMay 28, 2024 | finance.yahoo.com Get Bionano Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. BNGO Media Mentions By Week BNGO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNGO News Sentiment▼0.440.61▲Average Medical News Sentiment BNGO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNGO Articles This Week▼22▲BNGO Articles Average Week Get Bionano Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OWLT News MASS News OPXS News OPTX News CLIR News PRE News OMIC News MSAI News AATC News RPID News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNGO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionano Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionano Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
